Impact of Simeox ® Device in Bronchiectasis Patients: a quasi-experimental study
Extract Bronchiectasis is a chronic lung disease characterized by abnormal and irreversible dilatation of the bronchi, leading to excessive mucus accumulation, recurrent infections, and progressive lung damage. Impaired mucociliary clearance exacerbates disease progression and reduces quality of life (QoL) [1]. Airway clearance techniques (ACTs), including oscillating devices like Simeox®, are a core component of bronchiectasis management [2–4]. However, real-world data indicate that airway clearance management is not consistently implemented in clinical practice [5].
Authors
- Ana Sofia Barroso
- Cristina Alves (ORCID: https://orcid.org/0000-0001-8821-7797)
- Cátia Sofia Gabriel Caneiras (ORCID: https://orcid.org/0000-0002-3735-8554)
- Francisca Lopes (ORCID: https://orcid.org/0000-0001-7756-6465)
- Iolanda Mota
- Rita Gomes (ORCID: https://orcid.org/0000-0001-7934-3169)
- Jorge Ferreira
- Lucía Méndez
- Vanessa Santos (ORCID: https://orcid.org/0000-0002-1789-5969)
- José Coutinho Costa
- Margarida Silva
- Cristiana Cruz (ORCID: https://orcid.org/0009-0003-0117-9604)
Institutions
- Unidade Local de Saúde de Entre Douro e Vouga (PT)
Publication Details
- Journal
- ERJ Open Research
- Published
- 2026-10-15
- DOI
- https://doi.org/10.1183/23120541.00954-2026
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00